Follow-The-Filings

Security · featured owners

GALT Galectin Therapeutics Inc.

COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • $218K
  • 1 reduce

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 <0.01% Reduce −4.6% 46,968 $218K history

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 3.02,9.01
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
10-K
8-K 2.02,9.01
8-K 5.02,9.01
8-K 5.02
8-K 5.02

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Jul 31, 2026
4 Period Jul 14, 2026
4 Period Jun 26, 2026 · 2 forms
4 Period Jun 23, 2026
4 Period May 26, 2026
4 Period Mar 12, 2026
4 Period Feb 6, 2026
4/A Period Jan 16, 2026
4 Period Jan 16, 2026 · 12 forms
4 Period Jan 5, 2026
4 Period Jan 2, 2026 · 3 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$41.07M -$47.05M -$30.84M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $27.71M $17.25M $19.44M
Total non-current assets * $490,000 $243,000 $96,000
Total assets $28.2M $17.5M $19.53M
Total current liabilities $15.68M $35.41M $8.03M
Total non-current liabilities * $72.76M $85.16M $137.7M
Total equity -$61.96M -$104.79M -$127.92M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$32.96M -$41.77M -$23.88M
Cash from investing $0.00 $0.00 $0.00
Cash from financing $40.03M $31.23M $26.48M
Net change in cash * $7.07M -$10.54M $2.6M

ownership over time

filing count by report period · click a bar for that quarter’s holders